项目变更

Search documents
海兰信: 第六届监事会第十次会议决议公告
Zheng Quan Zhi Xing· 2025-06-10 11:37
Core Viewpoint - The company has approved a change in the implementation subject of a fundraising project and will provide loans to its subsidiary for project execution [1][2]. Group 1 - The sixth supervisory board meeting was held on June 9, 2025, with all three supervisors present, confirming compliance with relevant laws and company regulations [1]. - The company decided to change the implementation subject of the "UDC Shanghai Project (Phase I)" from itself to its subsidiary, Shanghai Hailan Cloud Data Technology Co., Ltd [1]. - The supervisory board believes that the decision-making process for the change is reasonable and aligns with the company's development strategy and legal regulations, benefiting the company and all shareholders [2]. Group 2 - The board's voting results showed unanimous support for the decision, with 3 votes in favor and no opposition or abstentions [2].
永泰运化工物流股份有限公司前次募集资金使用情况专项报告
Shang Hai Zheng Quan Bao· 2025-06-09 21:14
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:001228 证券简称:永泰运 公告编号:2025-043 永泰运化工物流股份有限公司 注1:NRA332006271013000809791账户期末余额为0.44元。 前次募集资金使用情况专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 根据中国证券监督管理委员会《监管规则适用指引一一发行类第7号》的相关规定,永泰运化工物流股 份有限公司(以下简称"公司")编制了截至2025年3月31日前次募集资金使用情况专项报告。 一、前次募集资金的数额、资金到账时间以及资金在专项账户的存放情况 (一)前次募集资金的数额与资金到账时间 根据中国证券监督管理委员会《关于核准永泰运化工物流股份有限公司首次公开发行股票的批复》(证 监许可〔2022〕707号),本公司由主承销商安信证券股份有限公司采用余额包销方式,向社会公众公 开发行普通股(A股)股票2,597万股,发行价为每股人民币30.46元,共计募集资金79,104.62万元,坐 扣承销和保荐费用7,367.00万元后的募集资金为71,737.62万元, ...
杰创智能: 第四届监事会第九次会议决议公告
Zheng Quan Zhi Xing· 2025-06-06 13:09
Group 1 - The company held its ninth meeting of the fourth Supervisory Board on June 6, 2025, with all three supervisors present, complying with relevant regulations [1][2] - The Supervisory Board approved the proposal to conclude and adjust certain fundraising projects, reallocating a total of 160.8871 million yuan (10,821.10 million yuan in surplus funds and 5,267.61 million yuan in remaining over-raised funds) to a new project, "Intelligent Cloud Service Construction and Operation Project" [1][2] - The decision to change the fundraising projects is aligned with the company's overall development strategy and aims to enhance the efficiency of fundraising utilization, benefiting all shareholders and meeting long-term development needs [2] Group 2 - The proposal's review process adhered to the regulations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange, ensuring the legality and validity of the voting results [2] - The voting outcome was unanimous, with 3 votes in favor and no opposition or abstentions, indicating strong support for the proposal [2] - The proposal will be submitted for further review at the company's shareholders' meeting [2]
荣晟环保: 浙江荣晟环保纸业股份有限公司第八届董事会第十五次会议决议公告
Zheng Quan Zhi Xing· 2025-06-06 09:43
Group 1 - The company held its 15th meeting of the 8th Board of Directors on June 6, 2025, with all 6 directors present, ensuring compliance with relevant laws and regulations [1] - The Board approved a proposal to change part of the fundraising investment projects for convertible bonds, which will be submitted to the shareholders' meeting and the bondholders' meeting for review [2][3] - The Board agreed to hold the second extraordinary shareholders' meeting on June 24, 2025, using a combination of on-site and online voting [2] - The Board also approved the proposal to convene the first bondholders' meeting for "Rong 23 Convertible Bonds" on June 24, 2025 [3]
鸿日达: 东吴证券股份有限公司关于鸿日达科技股份有限公司使用银行承兑汇票、信用证等票据支付募投项目部分款项并以募集资金等额置换的核查意见
Zheng Quan Zhi Xing· 2025-05-30 10:48
Core Viewpoint - The company plans to use bank acceptance bills and letters of credit to pay for part of the fundraising projects and will replace these payments with the raised funds, aiming to improve the efficiency of fund usage and reduce financial costs [1][7][9]. Fundraising Basic Situation - The company raised a total of RMB 75,438.20 million by issuing 51.67 million shares at RMB 14.60 per share, with actual funds received amounting to RMB 67,582.85 million after deducting issuance costs of RMB 7,855.35 million [1][2]. Fundraising Investment Project Situation - The company approved the use of RMB 57 million of excess funds to repay bank loans and made changes to the implementation of fundraising projects without altering the investment direction or total amount [2][3]. - The company has also approved the use of remaining funds from the "Kunshan Hanjing Precision Connector Production Project" for new projects, including "Semiconductor Metal Heat Sink Material Project" and "Automotive High-Frequency Signal Cable and Connector Project" [3][4]. Use of Bills and Letters of Credit - The company intends to use bank acceptance bills and letters of credit for payments, which will be replaced by the raised funds, following an internal approval process to ensure compliance and efficiency [6][7]. Impact on Daily Operations - The use of these financial instruments is expected to lower financial costs and enhance the flexibility of fund usage without affecting the normal progress of fundraising projects [7][9]. Approval Procedures and Opinions - The board and supervisory committee have reviewed and approved the use of bank acceptance bills and letters of credit, confirming that this does not change the direction of the raised funds and supports efficient fund usage [7][8].
美诺华: 中证鹏元关于关注宁波美诺华药业股份有限公司募投项目变更的公告
Zheng Quan Zhi Xing· 2025-05-20 10:20
根据公司于 2025 年 5 月 9 日发布的公告,公司于 2025 年 5 月 8 日召开股东大会和"美诺转债"2025 年第一次债券持有人会议,分 别审议通过《关于变更部分募集资金投资项目的议案》。根据公司于 目"部分募集资金用于"浙江美诺华药物化学有限公司(以下简称"浙 江美诺华")年产 734 吨医药原料药技术改造及绿色节能增效项目" (以下简称"新募投项目"),变更后原"高端制剂项目"将不再实 施。公司拟变更资金投向的金额共 13,834.70 万元及相应孳息 (具 体金额以实际结转时项目专户资金余额为准),将全部用于投入新募 投项目。 存储在美诺华及宁波美诺华医药科技有限公司(以下简称"医药科技")名下原项目募集资金专户。 表 1 变更后募集资金项目情况(单位:万元) 项 目 投 资 累 计 已 募 集 资 金 承 募集资金累 中证鹏元资信评估股份有限公司 中证鹏元公告【2025】234 号 中证鹏元关于关注宁波美诺华药业股份有限公司募投项目 变更的公告 中证鹏元资信评估股份有限公司(以下简称"中证鹏元")对宁 波美诺华药业股份有限公司(以下简称"美诺华"或"公司",股票 代码:603538.SH ...
晶合集成: 晶合集成2024年年度股东会会议资料
Zheng Quan Zhi Xing· 2025-05-16 09:22
Core Points - The company, Hefei Jinghe Integrated Circuit Co., Ltd., is preparing for its 2024 annual shareholders' meeting, focusing on various proposals including the 2025 restricted stock incentive plan and the confirmation of related party transactions for 2024 [1][2][3] Meeting Procedures - Shareholders and their representatives must sign in at least half an hour before the meeting, presenting necessary identification and documentation [2][3] - The meeting will follow a structured agenda, allowing shareholders to exercise their rights to speak, inquire, and vote [2][3][4] - Voting will be conducted both on-site and online, with results announced after the meeting [4][5] Proposals Overview - Proposal 1: Revision of the company's articles of association and related registration matters [6][9] - Proposal 2: Amendments to governance rules to enhance corporate governance [9] - Proposal 3: Termination of certain fundraising projects and reallocation of funds to other projects, specifically increasing investment in the 28nm logic and OLED chip process platform project [10][15] - Proposal 4: Implementation of the 2025 restricted stock incentive plan to attract and retain talent [16][19] - Proposal 5: Establishment of assessment management measures for the 2025 restricted stock incentive plan [18] - Proposal 6: Authorization for the board to manage the 2025 restricted stock incentive plan [19] - Proposal 7: Approval of the 2024 annual report and summary [21] - Proposal 8: Approval of the 2024 financial settlement report [22] - Proposal 9: Approval of the 2025 financial budget [22] - Proposal 10: Profit distribution plan for 2024, proposing a cash dividend of 1.00 yuan per 10 shares [22][23] - Proposal 11: Presentation of the 2024 board work report [24] - Proposal 12: Presentation of the 2024 supervisory board work report [25] - Proposal 13: Presentation of the 2024 independent directors' performance reports [25] - Proposal 14: Anticipated related party transactions for 2025 and confirmation of 2024 transactions [25]
派克新材去年净利下降46% 实控人拟减持套现
Zheng Quan Shi Bao Wang· 2025-05-13 15:27
Core Viewpoint - Parker New Material (605123) reported a decline in net profit and the controlling shareholder plans to reduce holdings due to personal needs [1] Group 1: Financial Performance - In 2024, Parker New Material achieved operating revenue of 3.213 billion yuan, a year-on-year decrease of 11.21% [1] - The net profit for 2024 was 264 million yuan, down 46.37% year-on-year [1] - The decline in performance was primarily attributed to reduced revenue from aerospace and petrochemical forgings [1] Group 2: Production and Sales - In 2024, the production volume of aerospace forgings was 3,763.44 tons, and the sales volume was 3,672.56 tons, representing year-on-year declines of 9.42% and 11% respectively [2] - The production volume of petrochemical forgings was 34,700 tons, with a sales volume of 36,500 tons, showing year-on-year declines of 15.51% and 17.84% respectively [2] Group 3: Strategic Adjustments - The company has recognized the decline in aerospace business and adjusted its fundraising projects accordingly [2] - In October of last year, Parker New Material announced a change in its previously planned fundraising project from "Intelligent Production Line for Special Alloy Structural Components for Aerospace" to "Intelligent Production Line for Large Special Alloy Forgings for High-end Equipment" [2][3] - The new project will be managed by the company's wholly-owned subsidiary, Wuxi Paixin Aerospace Technology Co., Ltd., with a total investment of 785 million yuan, of which 500 million yuan will come from raised funds [2][3] Group 4: Market Demand and Challenges - The company noted that the demand for forgings in sectors such as wind power, nuclear power, aerospace, and deep-sea equipment has been significant, particularly for large-sized forgings [3] - The existing forging production lines are unable to fully meet market demand due to capacity and size limitations [3] - The decision to change the fundraising project was based on a comprehensive assessment of expected investment, market demand, industry trends, and anticipated economic benefits [3]
华康股份(605077) - 华康股份2024年度募集资金年度存放与使用情况鉴证报告
2025-02-27 11:00
目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 浙江华康药业股份有限公司全体股东: 我们鉴证了后附的浙江华康药业股份有限公司(以下简称华康股份公司)管 理层编制的 2024 年度《关于募集资金年度存放与使用情况的专项报告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供华康股份公司年度报告披露时使用,不得用作任何其他目的。 我们同意将本鉴证报告作为华康股份公司年度报告的必备文件,随同其他文件一 起报送并对外披露。 二、管理层的责任 华康股份公司管理层的责任是提供真实、合法、完整的相关资料,按照《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求(2022 年 修订)》(证监会公告〔2022〕15 号)和《上海证券交易所上市公司自律监管 指引第 1 号——规范运作(2023 年 12 月修订)》(上证发〔2023〕193 号)的 规定编制《关于募集资金年度存放与使用情况的专项报告》,并保证其内容真实、 准确、完整,不存在虚假记载、误导性陈述或重大遗漏。 三、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对华康股份公司管理层编制的上述 报告独立地提出鉴证 ...